Diabetes: Abbott takes FreeStyle glucose monitor off the U.S. market

August 31, 2011 by MassDevice staff

Abbott permanently discontinues its FreeStyle Navigator glucose monitoring system for U.S. consumers due to repeated supply disruptions.

Abbott

Abbott Laboratories (NYSE:ABT) announced that it permanently discontinued its FreeStyle Navigator glucose monitor due to an inconsistent supply chain that has amounted to several disruptions in product availability for U.S. patients.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Comments

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp